Showing 1 - 10 of 221
Purpose – The purpose of this paper is to illustrate how a stakeholder approach based on a case-study research was used to define a method to be applied across the Portuguese seaport administrations (SA) in order to justify the tariffs to be charged for a variety of services provided by these...
Persistent link: https://www.econbiz.de/10014782058
Purpose – This paper aims to investigate the interaction between capital requirements and pricing constraints as measures for insurance regulation. Design/methodology/approach – In a theoretical model framework, the author derives the insurer’s shareholder-value-maximizing response to...
Persistent link: https://www.econbiz.de/10014901927
Alemayehu and Levenstein offer an industry perspective on ghoswriting. They propose some general principles to prevent the types of egregious cases that have been reported, but more specifics are needed to understand how to combat this serious problem.
Persistent link: https://www.econbiz.de/10014621208
Purpose The purpose of this paper is to benchmark current adoption of green chemistry (GC) practices by the innovative and generic pharmaceutical companies and examine the drivers, barriers and future opportunities. Design/methodology/approach The authors examined publicly available data for the...
Persistent link: https://www.econbiz.de/10014683748
Purpose – This paper aims to focus on the role of clusters as home and host country-specific advantages for multinational enterprises (“MNEs”) in the organization of their internal and external networks to optimize the diffusion and generation of new knowledge. Strategic asset-seeking...
Persistent link: https://www.econbiz.de/10014702643
The pharmaceutical business has long been a source of controversy, particularly the ability to market a drug for human consumption. The thalidomide disaster of the late 1950s and early 1960s invoked all nations in the 15 member states of the EU to require that a pharmaceutical product intended...
Persistent link: https://www.econbiz.de/10014713512
Suggests that the population of the EU will still need drugs whether or not the EU continues to have a pharmaceutical industry. Various policies trying to control health service drugs bills have affected the drugs industry: increasingly the effects are adverse. The EU Commission is now taking an...
Persistent link: https://www.econbiz.de/10014713530
, drug licensing, member state trade in pharmaceuticals, price and profit controls, and state aid. States none of these areas … and while there is a growing trend towards a single EU market in pharmaceuticals it is highly unlikely that a single …
Persistent link: https://www.econbiz.de/10014713570
Persistent link: https://www.econbiz.de/10014713952
Ireland is the tenth largest producer of drugs. From research undertaken during 1989‐92, aims to identify how Irish industrial policy influences US and European pharmaceutical multinationals to locate part of their global subsidiaries in the Republic of Ireland. Sent questionnaires to 70 chief...
Persistent link: https://www.econbiz.de/10014714686